Oral anticoagulants in extremely-high-risk, very elderly (&gt;90 years) patients with atrial fibrillation

Tze‐Fan Chao; Chern-En Chiang; Yi‐Hsin Chan; Jo‐Nan Liao; Tzeng‐Ji Chen; Professor Gregory Lip; Shih‐Ann Chen

doi:10.1016/j.hrthm.2021.02.018

Related publications

Article2020

Oral anticoagulants in extremely high risk very elderly (&gt;90 years) patients with Atrial Fibrillation

Tze‐Fan Chao, Professor Gregory Lip, S.A Chen

Article2018

Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation

Tze‐Fan Chao, Chia‐Jen Liu, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu, Ta‐Chuan Tuan, Jo‐Nan Liao, Fa‐Po Chung, Tzeng‐Ji Chen, Professor Gregory Lip, Shih‐Ann Chen

Article2022

Safety and efficacy of direct oral anticoagulants (DOACs) in very elderly patients (≥85 years old) with non-valvular atrial fibrillation

Claudia Rubino, Fabiana Blunda, Francesca Bodega, Francesco Melillo, Anita Russi, Paolo Mattiello, Anna Salerno, Michela Cera, Davide Margonato, Patrizio Mazzone, Paolo Della Bella, Alessandro Castiglioni, Ottavio Alfieri, Michele De Bonis, Matteo Montorfano, Massimo Filippi, Moreno Tresoldi, Alberto Cappelletti, Alberto Zangrillo, Alberto Margonato, Cosmo Godino

Article2021

Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk

Tze‐Fan Chao, Yi‐Hsin Chan, Chern‐En Chiang, Ta‐Chuan Tuan, Jo‐Nan Liao, Tzeng‐Ji Chen, Professor Gregory Lip, Shih‐Ann Chen

Article2018

P2246Effectiveness and safety of oral anticoagulants in patients aged 90 years or older with atrial fibrillation

Michela Giustozzi, Maria Cristina Vedovati, Melina Verso, Sergio Conti, Paolo Verdecchia, Giulio Bogliari, Lucia Pierpaoli, Giancarlo Agnelli, Cecilia Becattini

Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation

Discussion(0)

Related publications

Oral anticoagulants in extremely high risk very elderly (&gt;90 years) patients with Atrial Fibrillation

Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation

Safety and efficacy of direct oral anticoagulants (DOACs) in very elderly patients (≥85 years old) with non-valvular atrial fibrillation

Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk

P2246Effectiveness and safety of oral anticoagulants in patients aged 90 years or older with atrial fibrillation

Oral anticoagulants in extremely-high-risk, very elderly (&gt;90 years) patients with atrial fibrillation

Discussion(0)

Related publications

Oral anticoagulants in extremely high risk very elderly (&amp;gt;90 years) patients with Atrial Fibrillation

Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation

Safety and efficacy of direct oral anticoagulants (DOACs) in very elderly patients (≥85 years old) with non-valvular atrial fibrillation

Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk

P2246Effectiveness and safety of oral anticoagulants in patients aged 90 years or older with atrial fibrillation

Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation

Oral anticoagulants in extremely high risk very elderly (>90 years) patients with Atrial Fibrillation